• ๐ŸŒŽ Worldwide
    • ๐Ÿ‡บ๐Ÿ‡ธ U.S.
    • ๐Ÿ‡จ๐Ÿ‡ฆ Canada
    • ๐Ÿ‡ฌ๐Ÿ‡ง United Kingdom
    • ๐ŸŒ Asia
    • ๐ŸŒ Europe
    • ๐ŸŒŽ Latin America
    • ๐ŸŒ Oceania and Australasia
The Daily Marijuana Observer
SUBSCRIBE
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
No Result
View All Result
Home Events

GW Pharmaceuticals to Present at Upcoming Investor Conferences

Globe Newswire by Globe Newswire
November 22, 2019
in Events, Investments, Marijuana Stocks, Press Releases
GW Pharmaceuticals and Greenwich Biosciences Announce FDA Acceptance of sNDA Filing with Priority Review for EPIDIOLEXยฎ (cannabidiol) in the Treatment of Seizures Associated with Tuberous Sclerosis Complex
48
SHARES
ShareShare

CARLSBAD, Calif., Nov. 22, 2019 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that Justin Gover, GWโ€™s Chief Executive Officer, will present at two upcoming conferences:

  • Evercore ISI 2nd Annual HealthCONx Conference, on Wednesday, December 4th, 2019 at 10:15 a.m. EST
  • Piper Jaffray 31st Annual Healthcare Conference on Thursday, December 5th, 2019 at 8:30 a.m. EST

A live audio webcast of the presentations will be available through GWโ€™s corporate website atย www.gwpharm.comย on the Investors section under Events & Presentations. A replay will be available for each soon after the live presentation.

About GW Pharmaceuticals plc and Greenwich Biosciences, Inc.
Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GWโ€™s lead product, EPIDIOLEX (cannabidiol) oral solution is commercialized in the U.S. by its U.S. subsidiary Greenwich Biosciences for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome in patients two years of age or older. This product has received approval in Europe under the tradename EPIDYOLEX and is initially being commercialized in the 5 EU major markets. The Company continues to evaluate EPIDIOLEX in additional rare conditions including Tuberous Sclerosis Complex (TSC) and Rett syndrome. GW commercialized the worldโ€™s first plant-derived cannabinoid prescription drug, Sativexยฎ (nabiximols), which is approved for the treatment of spasticity due to multiple sclerosis in numerous countries outside the United States and for which the Company is now advancing a late stage program in order to seek FDA approval. The Company has a deep pipeline of additional cannabinoid product candidates which includes compounds in Phase 1 and 2 trials for epilepsy, autism, glioblastoma, and schizophrenia. For further information, please visitย www.gwpharm.com.

Share this:

  • Click to email this to a friend (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pocket (Opens in new window)
Tags: biotechFRA:GW2AGW Pharmaceuticals Plc.Justin GoverNASDAQ:GWPH

Get Real-Time Updates from MJobserver.com

Unsubscribe
Globe Newswire

Globe Newswire

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Related Posts

Epidiolex from GW Pharmaceuticals
Investments

Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader

February 3, 2021
Epidiolex from GW Pharmaceuticals
Investments

Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken symphony, a Breakthrough Innovation Created for the US Epilepsy Community

October 21, 2020
Epidiolex from GW Pharmaceuticals
Executives

GW Pharmaceuticals Announces the Appointment of David Gryska to its Board of Directors

September 10, 2020
Marinol Dronabinol THC Pharmaceutical
Events

30+ Expert Speakers to Present at the 3rd Annual Cannabinoid-Derived Pharmaceuticals Summit

July 9, 2020
Cannabis Clinical Trials
Health

Drug Trial Planned For Synthetic Cannabinoid COVID-19 Treatment

June 8, 2020
Cannabis News - Marijuana Becomes Legal in Michigan Starting December 6th
Press Releases

GW Pharmaceuticals to Host Virtual Investor Event on Its Nabiximols U.S. Development Program and Market Opportunity

June 4, 2020
Load More
Next Post
graft versus host disease and CBD

Published Studies Provide Further Support For Kalyteraโ€™s Program Evaluating CBD in GVHD

Leave a Comment! Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

๐Ÿšจ Subscribe to Stock Alerts

Get Live Updates on Breaking News

Subscribe Now

โœ‰๏ธ Subscribe to Our Newsletter!

* indicates required

๐Ÿ”Ž Search Marijuana Stocks

๐Ÿ“ฐ Recent News

  • Verano Holdings Enters into Agreement to Expand Arizona Footprint
  • Green Thumb Industries Announces Initial Public Offering in the U.S. to Raise US$100,000,000
  • Greenlane Announces Dismissal of Remaining Securities Class Action
  • Indiva Reports Record Market Share for January 2021
  • Acreage Announces Fourth Quarter And Full Year 2020 Earnings Date
Facebook Twitter Instagram LinkedIn Youtube

Cannabis News by Region

  • ๐Ÿ‡บ๐Ÿ‡ธ United States
  • ๐Ÿ‡จ๐Ÿ‡ฆ Canada
  • ๐Ÿ‡ฌ๐Ÿ‡ง United Kingdom
  • ๐ŸŒ Asia
  • ๐ŸŒ Europe
  • ๐ŸŒŽ Latin America
  • ๐ŸŒ Oceania and Australasia

Cannabis Tools & Resources

  • ๐Ÿ“… Calendar
  • ๐Ÿ“Š Databases
  • ๐Ÿ“‡ Directories
  • ๐Ÿ”” RSS Feeds
  • ๐Ÿ“บ Videos

Find Cannabis Business Services

  • โš–๏ธ Attorneys & Law Firms
  • ๐Ÿ“Š Accountants & Accounting Firms
  • ๐Ÿ’ก Consultants & Consulting Firms
  • ๐Ÿ“ฒ Marketing Agencies & Firms

The Daily Marijuana Observer

  • Subscribe
  • About MJobserver.com
  • Affiliate Marketing Disclosure
  • Legal Disclaimer
  • Privacy Policy
  • Contact Us

Advertise with Us

  • ๐Ÿ‘€ Advertise
  • ๐Ÿ“ฃ DMO Newswire
  • ๐Ÿ“‡ List in Our Databases

ยฉ 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observerโ„ข (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

No Result
View All Result
  • Home
  • Latest
  • ๐Ÿ”’ PRO
    • ๐Ÿ”’ A.M. Watchlist
    • ๐Ÿ”’ Analyst Action
  • ๐Ÿ’ผ Business
  • ๐Ÿ“ˆ Investments
    • ๐Ÿ“ˆ Stocks
    • ๐Ÿ’ฐ ETFs and Funds
    • ๐Ÿ’ญ Market Commentary
    • ๐Ÿ“ฐ Press Releases
    • ๐Ÿ“… Earnings Calendar
  • โš–๏ธ Law
    • Laws
    • Politics
    • Intellectual Property
    • Attorneys & Law Firms Database
  • ๐Ÿ‘ฅ People
    • โšฝ Athletes
    • ๐Ÿ’ผ Executives
    • ๐ŸŒŸ Celebrities
    • ๐Ÿ›’ Consumers
    • โš•๏ธ Doctors
    • ๐Ÿ’Š Patients
  • ๐Ÿ’Š Health
  • ๐Ÿ“‡ Databases
    • ๐Ÿ“ˆ Stock Databases
    • ๐Ÿ’ฐ Fund Databases
    • ๐Ÿ’ผ Service Providers Databases
    • ๐Ÿฆ Marijuana Stock Brokers
    • ๐Ÿ’ฒ Marijuana Cryptocurrencies

ยฉ 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observerโ„ข (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

Login to your account below

Forgotten Password? Sign Up

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.